Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Total Non-Current Liabilities (2016 - 2026)

Anika Therapeutics has reported Total Non-Current Liabilities over the past 17 years, most recently at $44.8 million for Q1 2026.

  • Quarterly Total Non-Current Liabilities rose 7.95% to $44.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $44.8 million through Mar 2026, up 7.95% year-over-year, with the annual reading at $46.1 million for FY2025, 3.91% down from the prior year.
  • Total Non-Current Liabilities was $44.8 million for Q1 2026 at Anika Therapeutics, down from $46.1 million in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $67.4 million in Q2 2022 and troughed at $39.3 million in Q2 2025.
  • The 5-year median for Total Non-Current Liabilities is $54.5 million (2023), against an average of $52.8 million.
  • The largest YoY upside for Total Non-Current Liabilities was 13.39% in 2022 against a maximum downside of 33.62% in 2022.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $63.2 million in 2022, then decreased by 8.24% to $58.0 million in 2023, then fell by 17.22% to $48.0 million in 2024, then fell by 3.91% to $46.1 million in 2025, then dropped by 2.92% to $44.8 million in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Total Non-Current Liabilities are $44.8 million (Q1 2026), $46.1 million (Q4 2025), and $41.9 million (Q3 2025).